Jeffrey B. Kindler - 10 Mar 2026 Form 4 Insider Report for PRECIGEN, INC. (PGEN)

Role
Director
Signature
/s/ Jeffrey B. Kindler, by Donald P. Lehr, as attorney-in-fact
Issuer symbol
PGEN
Transactions as of
10 Mar 2026
Net transactions value
$0
Form type
4
Filing time
12 Mar 2026, 16:27:40 UTC
Previous filing
10 Feb 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
KINDLER JEFFREY B Director 20374 SENECA MEADOWS PARKWAY, GERMANTOWN /s/ Jeffrey B. Kindler, by Donald P. Lehr, as attorney-in-fact 12 Mar 2026 0001174454

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PGEN Common Stock Award +19,658 +18% $3.51* 130,261 10 Mar 2026 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PGEN Restricted Stock Units Award +35,612 $0.000000* 35,612 10 Mar 2026 Common Stock 35,612 Direct F2, F3
transaction PGEN Option to Purchase Common Stock (Right to Buy) Award +41,073 $0.000000* 41,073 10 Mar 2026 Common Stock 41,073 $3.51 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares were issued to the reporting person in lieu of an annual retainer of $69,000.
F2 Each restricted stock unit ("RSU") represents a contingent right to receive one share of Precigen common stock.
F3 The RSUs vest in full on March 10, 2027.